Final FDA Quality Agreements Guidance Retains Focus On Commercial Manufacturing

Final US FDA guidance on contract manufacturing quality agreements retains draft version’s focus on commercial activities even though industry asked for it to also cover arrangements between manufacturers and contract partners developing investigational drugs.